"Revenue growth for ICRA sample set is estimated at 9-11 per cent in FY2022 and in FY2023, supported by gradual recovery post the impact of COVID-19," ICRA Assistant Vice-President and Sector Head Mythri Macherla said.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3sYWc7a
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Indian pharma industry estimated to grow 9-11% in 2021-22: ICRA
https://ift.tt/eA8V8J
No comments:
Post a Comment